Cell Culture Market worth $41.3 billion by 2026 – Exclusive Report by MarketsandMarkets™

cell culture market

Growth Factors Driving the Market: The growth of Cell Culture Market is majorly driven by the growing awareness about the benefits of cell-based vaccines, increasing demand for monoclonal antibodies (mAbs), funding for cell-based research, growing preference for single-use technologies, the launch of advanced cell culture products, and the growing focus on personalized medicine. On the other hand, the high cost of cell biology research is restraining the growth of this market.

In September 2021, Cytiva expanded its manufacturing capacity for bioprocessing single-use consumables by launching 3 new manufacturing facilities in under ten months.

MarketsandMarkets™ View on Revenue: The global cell culture market is projected to reach USD 41.3 billion by 2026 from USD 22.8 billion in 2021, at a CAGR of 12.6 % between 2021 and 2026.

Cell Culture Market
Cell Culture Market

Industry Segmentation in Detailed:

The consumables segment accounted for the largest share of the product segment in the cell culture market in 2020.

Based on product, the cell culture market is segmented into equipment and consumables. The cell culture equipment market is further segmented into supporting equipment, bioreactors, and storage equipment. The cell culture consumables market is segmented into sera, media & reagents, vessels, and bioreactor accessories. In 2020, the consumables segment accounted for the largest share of the market. The large share and high growth of the consumables segment can be attributed to the repeated purchase of consumables and an increase in funding for cell-based research.

The biopharmaceutical production segment accounted for the largest share of the application segment in the cell culture market in 2020.

Based on application, the cell culture market is categorized into biopharmaceutical production, diagnostics, drug discovery & development, tissue engineering & regenerative medicine, and other applications. The biopharmaceutical production segment is further divided into monoclonal antibody production, vaccine production, and other therapeutic protein production. The tissue engineering & regenerative medicine segment is further divided into cell & gene therapy and other tissue engineering & regenerative medicine applications. The biopharmaceutical production segment is estimated to grow at the highest CAGR of 14.1% during the forecast period. The high growth of this segment is attributed to the commercial expansion of major pharmaceutical and biotechnology companies, the increasing demand for mAbs, and the growing regulatory approvals for the production of cell culture-based vaccines.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=559

Leading Key Players Analysis:

Key players in the Cell Culture Market include Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany).

Geographical Trends in Detailed:

The global cell culture market has been segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. In 2020, North America accounted for the largest share of 39.6% of the cell culture market. The growing regulatory approvals for cell culture-based vaccines, technological advancements, growth in the biotechnology & pharmaceutical industries, higher investments in cell-based research, rising incidence of diseases such as cancer, and strong government support are the key factors driving the growth of the cell culture market in North America.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=559